Difficulty: Medium
Average Score: 65%
Practice
A 16-year-old adolescent is 6 weeks pregnant. The pregnancy has exacerbated her acne. She asks her CNM if she can resume taking her isotretinoin (Accutane) prescription, a category X drug, prescribed by her dermatologist. What is the most appropriate response by the CNM:
Correct answer
A
Rationale
The most appropriate response by the CNM to the 16-year-old adolescent is option A) "Accutane is known to cause birth defects and should never be taken during pregnancy." This response is correct because isotretinoin (Accutane) is a category X drug, which means it has been shown to have harmful effects on the fetus and should not be used during pregnancy.
Option B is incorrect because having a prescription does not automatically make a medication safe during pregnancy, especially in the case of category X drugs like isotretinoin. Option C is incorrect because reducing the dosage of Accutane during pregnancy does not eliminate the risk of birth defects associated with the drug. Option D is also incorrect as the CNM should not defer this decision to the dermatology provider but should provide immediate guidance on the potential risks of continuing Accutane during pregnancy.
This scenario highlights the importance of healthcare providers, including CNMs, being knowledgeable about medications and their safety profiles during pregnancy. It also underscores the critical role of patient education in understanding the risks and benefits of medication use, especially during vulnerable periods like pregnancy. It is crucial for healthcare providers to prioritize the health and well-being of both the adolescent and her developing fetus by providing accurate information and guidance on safe treatment options.
Option B is incorrect because having a prescription does not automatically make a medication safe during pregnancy, especially in the case of category X drugs like isotretinoin. Option C is incorrect because reducing the dosage of Accutane during pregnancy does not eliminate the risk of birth defects associated with the drug. Option D is also incorrect as the CNM should not defer this decision to the dermatology provider but should provide immediate guidance on the potential risks of continuing Accutane during pregnancy.
This scenario highlights the importance of healthcare providers, including CNMs, being knowledgeable about medications and their safety profiles during pregnancy. It also underscores the critical role of patient education in understanding the risks and benefits of medication use, especially during vulnerable periods like pregnancy. It is crucial for healthcare providers to prioritize the health and well-being of both the adolescent and her developing fetus by providing accurate information and guidance on safe treatment options.